Danae Urogenomics develops non-invasive, urine-based liquid biopsy tests to transform bladder cancer diagnosis and monitoring. With patented precision-medicine biomarkers and a multicenter clinical trial underway, we deliver faster, safer and more accurate tools to improve patient outcomes.